Literature DB >> 8532602

Permeability of the blood-brain barrier to melanocortins.

W A Banks1, A J Kastin.   

Abstract

Adrenocorticotropin (ACTH)-related compounds, termed melanocortins, produce a large number of effects on the central nervous system (CNS) after their peripheral administration. Some of the CNS effects of ACTH are mediated through the release of glucocorticoids from the adrenal gland, but there are fragments and analogues of ACTH that do not act on the adrenals. This raises the possibility that some blood-borne melanocortins may be acting directly on the brain, which would necessitate their crossing the blood-brain barrier (BBB). We review here the literature showing that melanocortins can affect the BBB in several ways, including an alteration of the permeability of the BBB to other substances.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532602     DOI: 10.1016/0196-9781(95)00043-j

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

1.  Melanocortins protect against multiple organ dysfunction syndrome in mice.

Authors:  Alessandra Bitto; Francesca Polito; Domenica Altavilla; Natasha Irrera; Daniela Giuliani; Alessandra Ottani; Letteria Minutoli; Luca Spaccapelo; Maria Galantucci; Renzo Lodi; Giuseppe Guzzo; Salvatore Guarini; Francesco Squadrito
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 2.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  The role of mPer2 clock gene in glucocorticoid and feeding rhythms.

Authors:  Shutong Yang; Aiyi Liu; Adam Weidenhammer; Robert C Cooksey; Donald McClain; Myung K Kim; Greti Aguilera; E Dale Abel; Jay H Chung
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.

Authors:  D Giuliani; C Mioni; C Bazzani; D Zaffe; A R Botticelli; S Capolongo; A Sabba; M Galantucci; A Iannone; P Grieco; E Novellino; G Colombo; A Tomasi; A Catania; S Guarini
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

6.  Adrenocorticotropic hormone elevates gene expression for catecholamine biosynthesis in rat superior cervical ganglia and locus coeruleus by an adrenal independent mechanism.

Authors:  L I Serova; V Gueorguiev; S-Y Cheng; E L Sabban
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

7.  Neuropeptide α-Melanocyte-Stimulating Hormone Promotes Neurological Recovery and Repairs Cerebral Ischemia/Reperfusion Injury in Type 1 Diabetes.

Authors:  Rajesh Kumar Goit; Tsz Chung Ng; Ka Cheung Tam; Jessica K W Tsang; Andrew W Taylor; Amy C Y Lo
Journal:  Neurochem Res       Date:  2021-09-29       Impact factor: 3.996

8.  The impact of acute psychosocial stress on magnetoencephalographic correlates of emotional attention and exogenous visual attention.

Authors:  Ludger Elling; Harald Schupp; Janine Bayer; Ann-Kathrin Bröckelmann; Christian Steinberg; Christian Dobel; Markus Junghofer
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

9.  Protection of cultured brain endothelial cells from cytokine-induced damage by α-melanocyte stimulating hormone.

Authors:  András Harazin; Alexandra Bocsik; Lilla Barna; András Kincses; Judit Váradi; Ferenc Fenyvesi; Vilmos Tubak; Maria A Deli; Miklós Vecsernyés
Journal:  PeerJ       Date:  2018-05-15       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.